Position in PBYI
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$103,984
-$183,287 QoQ
Shares Held
16,273
-66.3% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,278,083,995 across 390 Biotechnology names. PBYI ranks #206 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in PBYI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $103,984 | 16,273 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $287,271 | 48,281 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $172,739 | 32,531 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $96,129 | 28,026 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $69,406 | 23,448 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $69,933 | 22,929 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $42,847 | 16,803 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $53,627 | 16,450 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $44,074 | 8,316 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,346 | 311 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $775 | 295 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,020 | 289 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $840 | 272 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,129 | 267 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $616 | 260 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $721 | 253 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $404,625 | 140,495 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $655,934 | 215,768 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,801,743 | 257,025 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,060,633 | 224,470 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,120,475 | 218,156 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $832,494 | 81,140 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,028,048 | 101,888 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $954,385 | 91,504 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $768,613 | 91,068 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||